GABAB receptor association with the PDZ scaffold Mupp1 alters receptor stability and function

被引:67
作者
Balasubramanian, Srividya [1 ]
Fam, Sami R. [1 ]
Hall, Randy A. [1 ]
机构
[1] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA
关键词
D O I
10.1074/jbc.M607695200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
gamma-Aminobutyric acid, type B (GABA(B)) receptors are heterodimeric G protein-coupled receptors that mediate slow inhibitory synaptic transmission in the central nervous system. To identify novel interacting partners that might regulate GABAB receptor (GABA(B)R) functionality, we screened the GABA(B)R2 carboxyl terminus against a recently created proteomic array of 96 distinct PDZ (PSD-95/Dlg/ZO-1 homology) domains. The screen identified three specific PDZ domains that exhibit interactions with GABABR2: Mupp1 PDZ13, PAPIN PDZ1, and Erbin PDZ. Biochemical analysis confirmed that full-length Mupp1 and PAPIN interact with GABABR2 in cells. Disruption of the GABABR2 interaction with PDZ scaffolds by a point mutation to the carboxyl terminus of the receptor dramatically decreased receptor stability and attenuated the duration of GABAB receptor signaling. The effects of mutating the GABABR2 carboxyl terminus on receptor stability and signaling were mimicked by small interference RNA knockdown of endogenous Mupp1. These findings reveal that GABA, receptor stability and signaling can be modulated via GABABR2 interactions with the PDZ scaffold protein Mupp1, which may contribute to cell-specific regulation of GABA, receptors in the central nervous system.
引用
收藏
页码:4162 / 4171
页数:10
相关论文
共 58 条
  • [1] Ability of baclofen in reducing alcohol craving and intake: II - Preliminary clinical evidence
    Addolorato, G
    Caputo, F
    Capristo, E
    Colombo, G
    Gessa, GL
    Gasbarrini, G
    [J]. ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH, 2000, 24 (01): : 67 - 71
  • [2] Baclofen efficacy in reducing alcohol craving and intake: A preliminary double-blind randomized controlled study
    Addolorato, G
    Caputo, F
    Capristo, E
    Domenicali, M
    Bernardi, M
    Janiri, L
    Agabio, R
    Colombo, G
    Gessa, GL
    Gasbarrini, G
    [J]. ALCOHOL AND ALCOHOLISM, 2002, 37 (05): : 504 - 508
  • [3] Hetero-oligomerization between GABAA and GABAB receptors regulates GABAB receptor trafficking
    Balasubramanian, S
    Teissére, JA
    Raju, DV
    Hall, RA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (18) : 18840 - 18850
  • [4] Barritt DS, 2000, J CELL BIOCHEM, V79, P213, DOI 10.1002/1097-4644(20001101)79:2<213::AID-JCB50>3.0.CO
  • [5] 2-G
  • [6] Interaction of serotonin 5-hydroxytryptamine type 2C receptors with PDZ10 of the multi-PDZ domain protein MUPP1
    Bécamel, C
    Figge, A
    Poliak, S
    Dumuis, A
    Peles, E
    Bockaert, J
    Lübbert, H
    Ullmer, C
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (16) : 12974 - 12982
  • [7] GABAB receptors:: drugs meet clones
    Bettler, B
    Kaupmann, K
    Bowery, N
    [J]. CURRENT OPINION IN NEUROBIOLOGY, 1998, 8 (03) : 345 - 350
  • [8] GABAB receptor:: a site of therapeutic benefit
    Bowery, NG
    [J]. CURRENT OPINION IN PHARMACOLOGY, 2006, 6 (01) : 37 - 43
  • [9] International Union of Pharmacology.: XXXIII.: Mammalian γ-aminobutyric acidB receptors:: Structure and function
    Bowery, NG
    Bettler, B
    Froestl, W
    Gallagher, JP
    Marshall, F
    Raiteri, M
    Bonner, TI
    Enna, SJ
    [J]. PHARMACOLOGICAL REVIEWS, 2002, 54 (02) : 247 - 264
  • [10] Assembly-dependent surface targeting of the heterodimeric GABAB receptor is controlled by COPI but not 14-3-3
    Brock, C
    Boudier, L
    Maurel, D
    Blahos, J
    Pin, JP
    [J]. MOLECULAR BIOLOGY OF THE CELL, 2005, 16 (12) : 5572 - 5578